C-reactive protein is an acute-phase protein which rapidly increases a thousand-fold or more in response to inflammation and tissue damage. Both in adult rheumatoid arthritis'2 and in ankylosing spondylitis3 it may well be a more sensitive parameter of disease activity than the conventional erythrocyte sedimentation rate. In juvenile chronic arthritis only scant information is available.4 It was therefore decided to investigate the level of CRP early in the course of the disease.
Materials and methods
A single serum sample was obtained from 60 children with juvenile chronic arthritis seen early in the course of their disease. The children were subgrouped according to the mode of onset of the disease. For patients with a systemic onset the characteristic fever and rash were required, which could be accompanied by pericarditis, hepatomegaly, splenomegaly, or generalised lymphadenopathy. A polyarthritic onset required 5 or more joints to be affected in the first 3 months in the absence of serious systemic features, Accepted for publication 2 June 1981. *Rheumatologische Universitatspoliklinik Inselspital, 3010 Bern, Switzerland. Correspondence to Dr Barbara M. Ansell. while a pauciarticular onset had fewer than 5 joints affected, often asymmetrically distributed during the first 3 months.5 There were 20 patients in each such group, of whom all the children with systemic illness were seen within a few months of their first symptoms, as were 16 of the polyarthritic and 15 of the pauciarticular patients. The remainder were seen slightly later. Serial samples over a period of 2-6 years were available from 30 patients with either systemic or polyarticular disease. Twelve of this group developed amyloidosis confirmed by biopsy during the period for which specimens were available.
Sera were collected and stored at -20'C until estimation. The CRP levels were measured by the Fahey modification of the Mancini radial immunodiffusion technique.6 The plates were dried and Years from onset CRP and ESR levels tended to fall in those with systemic illness when their disease started to improve, possibly as the result of therapy (Fig. 2) . However, in the 5 patients in whom amyloidosis developed within 5 years of systemic onset the C-reactive protein has remained consistently high, and the correlation with the ESR was not as good ( Figs. 3 and 4) . Seven further patients in whom amyloidosis developed later in the course of the illness, for whom serial samples were available from our serum bank, showed similar high levels of CRP over months and in some cases years before the diagnostic confirmation by biopsy (Fig. 5 ). 
